Humanin is a small, 24-amino-acid peptide whose code is found in mitochondrial DNA, the separate set of genes inside the “power stations” of our cells. It was discovered in 2001 because it protected nerve cells from Alzheimer’s-related damage in the lab. Today it is one of the best-known mitochondrial-derived peptides, alongside MOTS-c.
If you have searched for humanin, you have probably also seen MOTS-c and SS-31 mentioned in the same breath. They are often grouped together as “mitochondrial peptides”, but they are quite different molecules. This Peptides UK guide explains, in plain English, what humanin is, what the research shows, and how it compares with MOTS-c and SS-31. For laboratory research use only.

What is humanin peptide in simple terms?
Most of your genes sit in the nucleus of each cell. Mitochondria, which make most of the cell’s energy, carry their own small loop of DNA. For a long time scientists thought this DNA only coded for a handful of energy-making proteins and the RNA needed to build them.
Humanin changed that view. Its code sits inside the stretch of mitochondrial DNA that makes 16S ribosomal RNA, and it turned out to be a short peptide that cells can release as a signal. That makes it a “mitochondrial-derived peptide” (MDP): a messenger that lets mitochondria talk to the rest of the cell and the body.
How was humanin discovered?
In 2001, a team led by Ikuo Nishimoto at Keio University in Tokyo screened for genes that could stop nerve cells dying when exposed to Alzheimer’s-linked genes and amyloid beta. One short gene did exactly that in cell culture, and they named its product humanin (Hashimoto et al., 2001). The protective effect depended on the peptide’s exact sequence, which pointed to a specific signalling role rather than a general chemical effect.
What does the research on humanin show?
Since 2001, research has moved from nerve cells to metabolism and ageing. Key findings include:
- Insulin action in rodents. Delivering humanin into the brain of rodents improved whole-body insulin sensitivity, and the effect ran through a signalling pathway in the hypothalamus called STAT-3. The same study found humanin levels fall with age in rodents and in human blood (Muzumdar et al., 2009).
- Lifespan and healthspan in animals. Extra humanin lengthened lifespan in tiny C. elegans worms, and middle-aged mice given the potent analogue HNG had better metabolic markers and fewer inflammatory markers. The same paper reported that children of centenarians had higher circulating humanin than age-matched controls (Yen et al., 2020).
- A protective variant. A rare humanin variant called P3S was found more often in centenarians carrying the APOE4 gene, a known Alzheimer’s risk factor. In mice, P3S reduced amyloid beta build-up in the brain more than standard humanin (Miller et al., 2024).
A 2023 systematic review pulls these strands together and describes humanin as a cytoprotective peptide that helps cells cope with stress (Coradduzza et al., 2023). It also makes clear that most of the evidence comes from cell and animal models.
Humanin’s “relatives”: small humanin-like peptides
Humanin is not alone. A computer search of the same 16S region found six more short peptides, named small humanin-like peptides, or SHLP1 to SHLP6. Two of them, SHLP2 and SHLP3, shared some of humanin’s protective effects on cells in the lab, and circulating SHLP2 also fell with age (Cobb et al., 2016).
Humanin vs MOTS-c vs SS-31: how do they compare?
These three peptides are often lumped together, but they differ in where they come from and what they have been studied for.
| Humanin | MOTS-c | SS-31 (elamipretide) | |
|---|---|---|---|
| Length | 24 amino acids | 16 amino acids | 4 amino acids |
| Origin | Natural, mtDNA 16S rRNA region | Natural, mtDNA 12S rRNA region | Synthetic, made in the lab |
| Type | Mitochondrial-derived peptide | Mitochondrial-derived peptide | Mitochondria-targeting peptide |
| Main research focus | Nerve-cell protection, insulin action, ageing | Skeletal muscle metabolism, AMPK, insulin sensitivity | Inner mitochondrial membrane, cardiolipin |
| Discovered or first reported | 2001 | 2015 | Developed as a synthetic peptide series |
MOTS-c
MOTS-c was reported in 2015 by a group at the University of Southern California. It is coded in the 12S rRNA region of mitochondrial DNA, seems to act mainly on skeletal muscle, and switches on an energy sensor called AMPK by affecting folate metabolism. In mice it protected against age-related and diet-related insulin resistance (Lee et al., 2015). Read more in our MOTS-c research guide.
SS-31
SS-31 is not made by the body at all. It is a short synthetic peptide designed to reach mitochondria and bind cardiolipin, a fat in the inner mitochondrial membrane that helps keep the energy-making machinery stable. It has been studied in clinical research in Barth syndrome, a rare inherited mitochondrial disorder that disrupts cardiolipin (Jacob et al., 2025).
What are the limits of the humanin evidence?
- Mostly cells and animals. The protective and metabolic effects come from cell culture, worms, mice and rats.
- Analogues, not always humanin. Many animal studies use HNG or other modified versions, so results do not automatically apply to natural humanin.
- Association is not cause. Higher humanin in centenarians’ children is a link, not proof that humanin causes long life.
- Industry ties. Some key authors have declared consulting and stock interests in a company developing mitochondrial peptides, as noted in the papers.
Sourcing mitochondrial peptides for UK research
Whichever mitochondrial peptide your lab studies, the same checks apply:
- Ask for a batch-matched Certificate of Analysis. HPLC shows purity and mass spectrometry confirms identity. Our guide on how to read a COA explains what each line means.
- Plan storage. Freeze-dried peptides keep best cold, dry and away from light. See our peptide storage guide.
- Compare suppliers on evidence. Our page on the best research peptides in the UK sets out what a supplier should show you before you order.
Peptides UK does not currently list humanin. For related mitochondrial research, we supply MOTS-c 10mg and SS-31, both HPLC and COA Verified, with COAs available on request by emailing [email protected]. You can browse the full range in our research peptide shop or see how to order.
Is humanin legal in the UK?
Humanin has no UK marketing authorisation, so it is not a licensed medicine. Research peptides are supplied in the UK for laboratory research use only. Whether a product counts as a medicine depends on how it is presented and used, so labs should follow current guidance from the MHRA and their own institutional rules. This article is not legal advice.
Frequently asked questions
What does humanin do?
In lab and animal studies, humanin acts as a protective signal. It was first found because it stopped nerve cells dying in cell models of Alzheimer’s disease, and later work linked it with insulin sensitivity and healthier ageing in mice and worms. Most of what is known comes from cells and animals, not people.
Is humanin the same as MOTS-c?
No. Both are mitochondrial-derived peptides, meaning their code sits in the DNA inside mitochondria, but they come from different genes. Humanin is 24 amino acids long and comes from the 16S rRNA region, while MOTS-c is 16 amino acids long and comes from the 12S rRNA region. They have been studied for different things.
Is SS-31 a mitochondrial-derived peptide?
No. SS-31, also called elamipretide, is a synthetic four-amino-acid peptide made in the lab. It is a mitochondria-targeting peptide: it travels to mitochondria and binds a fat called cardiolipin in their inner membrane. It is not made by the body.
What is HNG?
HNG is a modified version of humanin in which one amino acid is swapped. Researchers use it because it is much more potent than natural humanin in lab tests, so many animal studies use HNG rather than the original peptide.
Has humanin been tested in humans?
The human studies we found on ClinicalTrials.gov measure natural humanin levels in blood or tissue as a possible marker. We found no published trials that gave humanin itself to people. Humanin is not a licensed medicine in the UK.
NAD+ is sometimes discussed alongside mitochondrial peptides, but it is a dinucleotide coenzyme, not a peptide, and it is not the same as coenzyme Q10. Our guide Are NAD+ and CoQ10 the Same? explains the difference.
All Peptides UK products are for laboratory research use only. They are not medicines and are not for human or veterinary use. This article is for educational purposes and is not medical or legal advice.